Installed sterile capacity rises to 120 million units a year under isolator technology.
Commissioning of a second sterile fill-finish line raises installed capacity at the Calder Vale campus to roughly 120 million units a year.
The line runs vials and pre-filled syringes under isolator technology, with fully automated visual inspection on every unit.
Capacity that cannot be validated is not capacity.
Process-performance qualification is complete, and the line has entered routine commercial supply for two marketed products.
The expansion also adds redundancy: a planned maintenance shutdown on either line no longer interrupts national supply.